Based on SEC filing data. A pharmaceutical corporation based in Boston was founded in 2013 and has raised $20.5M in equity funding. The company is currently in its growth stage of development.
Get notified the moment RHYTHM METABOLIC, INC. (RYTM) files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.